Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Nov;16(11):617-618.
doi: 10.1038/s41574-020-00414-9.

Understanding the ever-changing incidence of thyroid cancer

Affiliations

Understanding the ever-changing incidence of thyroid cancer

Cari M Kitahara et al. Nat Rev Endocrinol. 2020 Nov.

Abstract

This Comment article provides a behind-the-scenes perspective and update of our 2016 Review, which discussed possible factors contributing to thyroid cancer incidence trends worldwide. We also highlight promising research directions that are improving the understanding of thyroid cancer aetiology.

PubMed Disclaimer

Conflict of interest statement

J.A.S. is a member of the Data Monitoring Committee of the Medullary Thyroid Cancer Consortium Registry supported by GlaxoSmithKline, Novo Nordisk, AstraZeneca and Eli Lilly. J.A.S. receives institutional research funding from Exelixis and Eli Lilly. C.M.K. declares no competing interests.

Figures

Fig. 1
Fig. 1. Age-standardized incidence rates of papillary thyroid cancer (overall and large (>4 cm) among people aged ≥60 years in the US Surveillance, Epidemiology, and End Results — 13 cancer registry program, 1995–2015).
The rates of papillary thyroid cancer are shown as overall rates and have been stratified as attributable to overweight or obesity or as being unrelated to overweight or obesity. Annual population attributable fractions are based on relative risk estimates from the NIH–AARP Diet and Health Study and prevalence estimates of overweight and obesity among US adults aged ≥50 years from the National Health Interview Survey (1985−2005). The arrows represent the hypothetical reduction in the incidence rates for papillary thyroid cancer in the absence of overweight and obesity in the 10 years before the date of diagnosis. Please note the 10-fold difference in scale of the y axes. Adapted with permission from ref., Oxford University Press.

References

    1. Kitahara CM, Sosa JA. The changing incidence of thyroid cancer. Nat. Rev. Endocrinol. 2016;12:646–653. doi: 10.1038/nrendo.2016.110. - DOI - PMC - PubMed
    1. Sosa JA, et al. Increases in thyroid nodule fine-needle aspirations, operations, and diagnoses of thyroid cancer in the United States. Surgery. 2013;154:1420–1426. doi: 10.1016/j.surg.2013.07.006. - DOI - PubMed
    1. Haymart MR, et al. Use of radioactive iodine for thyroid cancer. JAMA. 2011;306:721–728. doi: 10.1001/jama.2011.1139. - DOI - PMC - PubMed
    1. Haugen BR. 2015 American Thyroid Association Management Guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: what is new and what has changed? Cancer. 2017;123:372–381. doi: 10.1002/cncr.30360. - DOI - PubMed
    1. US Preventive Services Task Force Screening for thyroid cancer: US Preventive Services Task Force Recommendation Statement. JAMA. 2017;317:1882–1887. doi: 10.1001/jama.2017.4011. - DOI - PubMed

Publication types